Actuate Therapeutics, Inc. DEFA14A Filing

Ticker: ACTU · Form: DEFA14A · Filed: May 6, 2026 · CIK: 0001652935

Actuate Therapeutics, Inc. DEFA14A Filing Summary
FieldDetail
CompanyActuate Therapeutics, Inc. (ACTU)
Form TypeDEFA14A
Filed DateMay 6, 2026
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a DEFA14A filing submitted by Actuate Therapeutics, Inc. (ticker: ACTU) to the SEC on May 6, 2026.

Where can I view the full DEFA14A filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 6, 2026 regarding ACTUATE THERAPEUTICS, INC. (ACTU).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.